Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2018 , Vol 56 , Num 2
Abstract PDF Similar Articles Mail to Author
Synthesis of Radioiodinated Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle (125I-TQG-Fe3O4) and its Cytotoxicity and In Vitro Affinity
İskender İnce 1-2 Zümrüt Biber Müftüler 2 E. İlker Medine 2 Özge Kozguş Güldü 2 Volkan Tekin 2 Selin Aktar 3 Erdem Göker 4 Perihan Ünak 2
1 Ege University, Center for Drug R&D and Pharmacokinetic Applications (ARGEFAR), 35100
2 Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, 35100
3 Ege University Faculty of Pharmacy, Department of Pharmaceutical Botany, Izmir 35100
4 Ege University School of Medicine, Division of Medical Oncology, Tulay Aktas Oncology Hospital, 35100
DOI : 10.23893/1307-2080.APS.05608 Viewed : 16873 - Downloaded : 4942 Keywords :

Istanbul Medipol University